Enhanced radiation late effects and cellular radiation sensitivity in an ATM heterozygous breast cancer patient

Radiation Oncology Investigations

Volumn 7, Issue 4, 1999, Pages 231-237

  Varghese, Susan ^a   Schmidt Ullrich, Rupert K ^b   Dritschilo, Anatoly ^a   Jung, Mira ^a,c  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Radiation Research   (United States)

Author keywords

Ataxia telangiectasia; Breast cancer; Mutated gene ATM; Protein truncation test; Radiation sensitivity

Indexed keywords

ADULT; ARTICLE; ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASE REPORT; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY;

EID: 0032885580     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:4<231::AID-ROI4>3.0.CO;2-S     Document Type: Article

References (21)

1. Harris JR, Hellman S, Silen W. Conservative management of breast cancer: new surgical and radiotherapeutic techniques. New York: Lippincott Press; 1983. p 11-21.
2. Jacobson JA, Danforth DN, Cowan KH, D'angelo T, Steinberg ST, Pierce L, Lippman ME, Lichter AS, Glastein E, Okunieff P. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995; 332:907-911.
3. Weichselbaum R, Epstein J, Little JB. In vitro radiosensitivity of human diploid fibroblasts derived from patients with unusual clinical responses to radiation. Radiology 1976;121:479-482.
4. Morris MM, Powell SN. Irradiation in the setting of collagen vascular disease: acute and late complications. J Clin Oncol 1997;15:2728-2735.
5. Busch D. Genetic susceptibility to radiation and chemotherapy injury: diagnosis and management. Int J Radiat Oncol Biol Phys 1994;30:997-1002.
6. Taylor AMR, Harndon DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Bridges BA. Ataxia telangiectasia, a human mutation with abnormal radiation sensitivity. Nature 1975;258:427-429.
7. Hustinix TWJ, Scheres JMJC, Weemaes CMR, Ter Harr BGA, Janssen AH. Karyotype instability with multiple 7/14 and 7/7 rearrangements. Hum Genet 1979;49:199-208.
8. Patterson MC et al. Enhanced radiosensitivity of cultured fibroblasts from ataxia- telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic gamma-radiation. Cancer Res 1979;39:3725-3734.
9. Swift M. et al. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 1987;316:1289-1294.
10. Pippard EC, Hall AJ, Barker DJP, Bridges BA. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 1988;48:2929-2932.
11. Savitsky K et al. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268:1749-1753.
12. Ramsay J, Birrell G, Lavin M. Breast cancer and radiotherapy in ataxia-telangiectasia heterozygote. Lancet 1996;347:1627.
13. Gilad S et al. Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet 1996;5:433-439.
14. FitzGerald M et al. Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 1997;15:307-310.
15. Vorechovsky I. et al. The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 1996;56:2726-2732.
16. Gardner RJ, Bobrow M, Roberts RG. The identification of point mutations in Duchenne muscular dystrophy patients by using reverse-transcription PCR and the protein truncation test. Am J Hum Genet 1995;57:311-320.
17. Abright N. Computer programs for the analysis of cellular survival data. Radiat Res 1987;112:331-340.
18. Jung M, Zhang Y, Lee S, Dritschilo A. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated IκB-α. Science 1995;268:1619-1621.
19. Arlett CF, Green MHL, Priestley A, Harcourt SA, Wayne LV. Comparative human cellular radiosensitivity. I. The effect of SV40 transformation an immortalization on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes. Int J Radiat Biol 1988;54:911-928.
20. Morgan SE, Lovly C, Pandita TK, Shiloh Y, Kartan MB. Fragments of ATM which have dominant-negative or complementing activity. Mol Cell Biol 1997;17:2020-2029.
21. Okunieff P, Morgan D, Niemierko A, Suit HD. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys 1995;32:1227-1237.